学术探索
学术期刊
新闻热点
数据分析
智能评审
立即登录
PHASE-II STUDY OF THE THYMIDYLATE SYNTHETASE INHIBITOR CB3717 (N10-PROPARGYL-5, 8-DIDEAZAFOLIC ACID) IN COLORECTAL-CANCER
被引:18
作者
:
HARDING, MJ
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV NEWCASTLE UPON TYNE, DEPT CLIN ONCOL, NEWCASTLE NE4 6BE, ENGLAND
UNIV NEWCASTLE UPON TYNE, DEPT CLIN ONCOL, NEWCASTLE NE4 6BE, ENGLAND
HARDING, MJ
[
1
]
CANTWELL, BMJ
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV NEWCASTLE UPON TYNE, DEPT CLIN ONCOL, NEWCASTLE NE4 6BE, ENGLAND
UNIV NEWCASTLE UPON TYNE, DEPT CLIN ONCOL, NEWCASTLE NE4 6BE, ENGLAND
CANTWELL, BMJ
[
1
]
MILSTEAD, RAV
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV NEWCASTLE UPON TYNE, DEPT CLIN ONCOL, NEWCASTLE NE4 6BE, ENGLAND
UNIV NEWCASTLE UPON TYNE, DEPT CLIN ONCOL, NEWCASTLE NE4 6BE, ENGLAND
MILSTEAD, RAV
[
1
]
HARRIS, AL
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV NEWCASTLE UPON TYNE, DEPT CLIN ONCOL, NEWCASTLE NE4 6BE, ENGLAND
UNIV NEWCASTLE UPON TYNE, DEPT CLIN ONCOL, NEWCASTLE NE4 6BE, ENGLAND
HARRIS, AL
[
1
]
KAYE, SB
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV NEWCASTLE UPON TYNE, DEPT CLIN ONCOL, NEWCASTLE NE4 6BE, ENGLAND
UNIV NEWCASTLE UPON TYNE, DEPT CLIN ONCOL, NEWCASTLE NE4 6BE, ENGLAND
KAYE, SB
[
1
]
机构
:
[1]
UNIV NEWCASTLE UPON TYNE, DEPT CLIN ONCOL, NEWCASTLE NE4 6BE, ENGLAND
来源
:
BRITISH JOURNAL OF CANCER
|
1988年
/ 57卷
/ 06期
关键词
:
D O I
:
10.1038/bjc.1988.143
中图分类号
:
R73 [肿瘤学];
学科分类号
:
100214 ;
摘要
:
引用
收藏
页码:628 / 629
页数:2
相关论文
共 4 条
[1]
BENZ C, 1981, CANCER RES, V41, P994
[2]
A CONTROLLED EVALUATION OF RECENT APPROACHES TO BIOCHEMICAL MODULATION OR ENHANCEMENT OF 5-FLUOROURACIL THERAPY IN COLORECTAL-CARCINOMA
[J].
BUROKER, TR
论文数:
0
引用数:
0
h-index:
0
机构:
IOWA ONCOL RES ASSOC CCOP, DES MOINES, IA USA
BUROKER, TR
;
MOERTEL, G
论文数:
0
引用数:
0
h-index:
0
机构:
IOWA ONCOL RES ASSOC CCOP, DES MOINES, IA USA
MOERTEL, G
;
FLEMING, TR
论文数:
0
引用数:
0
h-index:
0
机构:
IOWA ONCOL RES ASSOC CCOP, DES MOINES, IA USA
FLEMING, TR
;
EVERSON, LK
论文数:
0
引用数:
0
h-index:
0
机构:
IOWA ONCOL RES ASSOC CCOP, DES MOINES, IA USA
EVERSON, LK
;
CULLINAN, SA
论文数:
0
引用数:
0
h-index:
0
机构:
IOWA ONCOL RES ASSOC CCOP, DES MOINES, IA USA
CULLINAN, SA
;
KROOK, JE
论文数:
0
引用数:
0
h-index:
0
机构:
IOWA ONCOL RES ASSOC CCOP, DES MOINES, IA USA
KROOK, JE
;
MAILLIARD, JA
论文数:
0
引用数:
0
h-index:
0
机构:
IOWA ONCOL RES ASSOC CCOP, DES MOINES, IA USA
MAILLIARD, JA
;
MARSCHKE, RF
论文数:
0
引用数:
0
h-index:
0
机构:
IOWA ONCOL RES ASSOC CCOP, DES MOINES, IA USA
MARSCHKE, RF
;
KLAASSEN, DJ
论文数:
0
引用数:
0
h-index:
0
机构:
IOWA ONCOL RES ASSOC CCOP, DES MOINES, IA USA
KLAASSEN, DJ
;
LAURIE, JA
论文数:
0
引用数:
0
h-index:
0
机构:
IOWA ONCOL RES ASSOC CCOP, DES MOINES, IA USA
LAURIE, JA
;
MOON, MD
论文数:
0
引用数:
0
h-index:
0
机构:
IOWA ONCOL RES ASSOC CCOP, DES MOINES, IA USA
MOON, MD
.
JOURNAL OF CLINICAL ONCOLOGY,
1985,
3
(12)
:1624
-1631
[3]
A PHASE-I EVALUATION OF THE QUINAZOLINE ANTIFOLATE THYMIDYLATE SYNTHASE INHIBITOR, N-10-PROPARGYL-5,8-DIDEAZAFOLIC ACID, CB3717
[J].
CALVERT, AH
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
CALVERT, AH
;
ALISON, DL
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
ALISON, DL
;
HARLAND, SJ
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
HARLAND, SJ
;
ROBINSON, BA
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
ROBINSON, BA
;
JACKMAN, AL
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
JACKMAN, AL
;
JONES, TR
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
JONES, TR
;
NEWELL, DR
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
NEWELL, DR
;
SIDDIK, ZH
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
SIDDIK, ZH
;
WILTSHAW, E
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
WILTSHAW, E
;
MCELWAIN, TJ
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
MCELWAIN, TJ
;
SMITH, IE
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
SMITH, IE
;
HARRAP, KR
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
HARRAP, KR
.
JOURNAL OF CLINICAL ONCOLOGY,
1986,
4
(08)
:1245
-1252
[4]
A POTENT ANTI-TUMOR QUINAZOLINE INHIBITOR OF THYMIDYLATE SYNTHETASE - SYNTHESIS, BIOLOGICAL PROPERTIES AND THERAPEUTIC RESULTS IN MICE
[J].
JONES, TR
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
JONES, TR
;
CALVERT, AH
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
CALVERT, AH
;
JACKMAN, AL
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
JACKMAN, AL
;
BROWN, SJ
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
BROWN, SJ
;
JONES, M
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
JONES, M
;
HARRAP, KR
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
HARRAP, KR
.
EUROPEAN JOURNAL OF CANCER,
1981,
17
(01)
:11
-19
←
1
→
共 4 条
[1]
BENZ C, 1981, CANCER RES, V41, P994
[2]
A CONTROLLED EVALUATION OF RECENT APPROACHES TO BIOCHEMICAL MODULATION OR ENHANCEMENT OF 5-FLUOROURACIL THERAPY IN COLORECTAL-CARCINOMA
[J].
BUROKER, TR
论文数:
0
引用数:
0
h-index:
0
机构:
IOWA ONCOL RES ASSOC CCOP, DES MOINES, IA USA
BUROKER, TR
;
MOERTEL, G
论文数:
0
引用数:
0
h-index:
0
机构:
IOWA ONCOL RES ASSOC CCOP, DES MOINES, IA USA
MOERTEL, G
;
FLEMING, TR
论文数:
0
引用数:
0
h-index:
0
机构:
IOWA ONCOL RES ASSOC CCOP, DES MOINES, IA USA
FLEMING, TR
;
EVERSON, LK
论文数:
0
引用数:
0
h-index:
0
机构:
IOWA ONCOL RES ASSOC CCOP, DES MOINES, IA USA
EVERSON, LK
;
CULLINAN, SA
论文数:
0
引用数:
0
h-index:
0
机构:
IOWA ONCOL RES ASSOC CCOP, DES MOINES, IA USA
CULLINAN, SA
;
KROOK, JE
论文数:
0
引用数:
0
h-index:
0
机构:
IOWA ONCOL RES ASSOC CCOP, DES MOINES, IA USA
KROOK, JE
;
MAILLIARD, JA
论文数:
0
引用数:
0
h-index:
0
机构:
IOWA ONCOL RES ASSOC CCOP, DES MOINES, IA USA
MAILLIARD, JA
;
MARSCHKE, RF
论文数:
0
引用数:
0
h-index:
0
机构:
IOWA ONCOL RES ASSOC CCOP, DES MOINES, IA USA
MARSCHKE, RF
;
KLAASSEN, DJ
论文数:
0
引用数:
0
h-index:
0
机构:
IOWA ONCOL RES ASSOC CCOP, DES MOINES, IA USA
KLAASSEN, DJ
;
LAURIE, JA
论文数:
0
引用数:
0
h-index:
0
机构:
IOWA ONCOL RES ASSOC CCOP, DES MOINES, IA USA
LAURIE, JA
;
MOON, MD
论文数:
0
引用数:
0
h-index:
0
机构:
IOWA ONCOL RES ASSOC CCOP, DES MOINES, IA USA
MOON, MD
.
JOURNAL OF CLINICAL ONCOLOGY,
1985,
3
(12)
:1624
-1631
[3]
A PHASE-I EVALUATION OF THE QUINAZOLINE ANTIFOLATE THYMIDYLATE SYNTHASE INHIBITOR, N-10-PROPARGYL-5,8-DIDEAZAFOLIC ACID, CB3717
[J].
CALVERT, AH
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
CALVERT, AH
;
ALISON, DL
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
ALISON, DL
;
HARLAND, SJ
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
HARLAND, SJ
;
ROBINSON, BA
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
ROBINSON, BA
;
JACKMAN, AL
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
JACKMAN, AL
;
JONES, TR
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
JONES, TR
;
NEWELL, DR
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
NEWELL, DR
;
SIDDIK, ZH
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
SIDDIK, ZH
;
WILTSHAW, E
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
WILTSHAW, E
;
MCELWAIN, TJ
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
MCELWAIN, TJ
;
SMITH, IE
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
SMITH, IE
;
HARRAP, KR
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, MED SECT, SUTTON SM2 5PX, SURREY, ENGLAND
HARRAP, KR
.
JOURNAL OF CLINICAL ONCOLOGY,
1986,
4
(08)
:1245
-1252
[4]
A POTENT ANTI-TUMOR QUINAZOLINE INHIBITOR OF THYMIDYLATE SYNTHETASE - SYNTHESIS, BIOLOGICAL PROPERTIES AND THERAPEUTIC RESULTS IN MICE
[J].
JONES, TR
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
JONES, TR
;
CALVERT, AH
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
CALVERT, AH
;
JACKMAN, AL
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
JACKMAN, AL
;
BROWN, SJ
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
BROWN, SJ
;
JONES, M
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
JONES, M
;
HARRAP, KR
论文数:
0
引用数:
0
h-index:
0
机构:
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
INST CANC RES, DEPT BIOCHEM PHARMACOL, SUTTON SM2 5PX, SURREY, ENGLAND
HARRAP, KR
.
EUROPEAN JOURNAL OF CANCER,
1981,
17
(01)
:11
-19
←
1
→